Rate My Professor Carolyn Porteous

Porteous has contributed to 23 peer-reviewed publications, primarily focused on mitochondria-targeted antioxidants, oxidative stress, lipid metabolism, atherosclerosis, and related cardiovascular mechanisms. Key publications include 'Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice' (2020), 'Proteomic Analysis of Liver from Human Lipoprotein(a) Transgenic Mice Shows an Oxidative Stress and Lipid Export Response' (2018), 'Assessing the Mitochondrial Membrane Potential in Cells and In Vivo using Targeted Click Chemistry and Mass Spectrometry' (2015), 'Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice' (2014), 'P-glycoprotein (Mdr1a/b) and Breast Cancer Resistance Protein (BCRP) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain' (2013), 'A Mitochondria-Targeted Macrocyclic Mn(II) Superoxide Dismutase Mimetic' (2012), 'Using the mitochondria-targeted ratiometric mass spectrometry probe MitoB to measure H2O2 in living Drosophila' (2012), 'Measurement of H2O2 within Living Drosophila during Aging Using a Ratiometric Mass Spectrometry Probe Targeted to the Mitochondrial Matrix' (2011), 'Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: Implications for mitochondria-specific therapies and probes' (2010), and 'Mitochondria-Targeted Antioxidants in the Treatment of Disease' (2009). Her contributions have accumulated 5,025 citations and 7,548 reads on ResearchGate. She is acknowledged for technical assistance in studies such as 'Associations between heart size and anthropometric and demographic characteristics' (2024) and 'Enhancing the peroxidase activity of cytochrome c by mutation' (2014), demonstrating her long-standing impact on biomedical research at the University of Otago.